EP1171202A1 - Surveillance peroperatoire des modifications tissulaires induites par la temperature a l'aide d'un appareil de radiographie numerique a haute resolution au cours d'une thermotherapie - Google Patents
Surveillance peroperatoire des modifications tissulaires induites par la temperature a l'aide d'un appareil de radiographie numerique a haute resolution au cours d'une thermotherapieInfo
- Publication number
- EP1171202A1 EP1171202A1 EP00926246A EP00926246A EP1171202A1 EP 1171202 A1 EP1171202 A1 EP 1171202A1 EP 00926246 A EP00926246 A EP 00926246A EP 00926246 A EP00926246 A EP 00926246A EP 1171202 A1 EP1171202 A1 EP 1171202A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tissue
- ray
- image signal
- volume
- ray image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 59
- 238000000015 thermotherapy Methods 0.000 title claims description 34
- 238000000034 method Methods 0.000 claims abstract description 64
- 230000001939 inductive effect Effects 0.000 claims abstract description 33
- 238000013500 data storage Methods 0.000 claims description 33
- 238000005286 illumination Methods 0.000 claims description 30
- 239000000523 sample Substances 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 15
- 230000003068 static effect Effects 0.000 claims description 14
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 4
- 206010020843 Hyperthermia Diseases 0.000 claims description 3
- 230000036031 hyperthermia Effects 0.000 claims description 3
- 238000009877 rendering Methods 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims 6
- 210000001519 tissue Anatomy 0.000 description 124
- 206010028980 Neoplasm Diseases 0.000 description 56
- 238000002474 experimental method Methods 0.000 description 50
- 238000010304 firing Methods 0.000 description 26
- 239000000835 fiber Substances 0.000 description 21
- 230000008859 change Effects 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 238000002560 therapeutic procedure Methods 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 238000003384 imaging method Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 9
- 239000013307 optical fiber Substances 0.000 description 9
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 9
- 239000004926 polymethyl methacrylate Substances 0.000 description 9
- 206010006187 Breast cancer Diseases 0.000 description 8
- 208000026310 Breast neoplasm Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000006835 compression Effects 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000012935 Averaging Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000013532 laser treatment Methods 0.000 description 5
- 238000012806 monitoring device Methods 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 238000000429 assembly Methods 0.000 description 4
- 230000000712 assembly Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 1
- 208000016623 Choroid neoplasm Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 238000010317 ablation therapy Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000002588 choroid cancer Diseases 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000012625 in-situ measurement Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 238000009607 mammography Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000001931 thermography Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B2018/2005—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser with beam delivery through an interstitially insertable device, e.g. needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
- A61B5/015—By temperature mapping of body part
Definitions
- This invention pertains to intraoperative monitoring methods and devices, and more particularly to intraoperative monitoring devices and methods for monitoring temperature-induced changes to tissue with high resolution digital X-ray imaging and inducing the changes to the tissue.
- thermotherapy has been considered, and or applied to the treatment of cancers.
- Laser interstitial thermotherapy (LITT) has received attention as a surgical procedure for the treatment of cancer tumors, and particularly with respect to liver, head, neck and breast cancer.
- Laser interstitial thermotherapy is a surgical procedure for the treatment of cancer tumors in which near infra-red laser energy is delivered to the tumor site inside the body through a flexible fiber-optic probe.
- Some fiber optic probes in use terminate with a light diffusing tip.
- the infra-red laser radiation is absorbed by the tumor cells, which results in a temperature increase and subsequent cell death of the tumor cells.
- the temperature distribution around the light-diffusing tip, and thus the extent of cell-death, is a function of the laser parameters, treatment time, tumor size, and shape, fiber optic tip geometry, optical properties of the tumor, and blood perfusion rates in both compressed and uncompressed treatment sites.
- the treatment parameters e.g., wavelength, power, duration, tip geometry, and tip location and orientation
- the treatment parameters must be selected so as to minimize collateral damage to healthy tissue surrounding the tumor, yet still must ensure reliable total tumor destruction. Because of tissue inhomogeneities, and inter- patient variability of the physical and biological properties of tumors, intraoperative monitoring of the treatment effect is highly desirable.
- intraoperative monitoring of LITT is conducted with magnetic resonance imaging (MRI) or three-dimensional ultra-sound, or by measuring the temperature at discrete locations in-situ with thermo-couples or thermo- sensing fluorescent probes.
- Intraoperative monitoring with MRI has numerous disadvantages which include being expensive and not being able to be used with metal protected light guides which are currently used for the LITT probe.
- Three- dimensional ultra-sound imaging techniques are currently at an experimental stage and have not been sufficiently developed.
- In situ thermo-couples or fluorescence-based temperature probes only provide temperatures at a relatively small number of points throughout the tissue being monitored.
- Currently, only fluorescence-based temperature probes are approved by the FDA for clinical use.
- thermotherapy includes real-time monitoring of temperature induced changes to tissue during thermotherapy using X-ray imaging for feedback information used during the thermotherapy.
- a device for monitoring thermally-induced changes to localized regions of tissue which has an X-ray illumination source, an X-ray detector, a data storage unit in communication with the X-ray detector, an image comparison unit in comparison with at least the data storage unit and an image display unit in communication with the image comparison unit.
- the X-ray illumination source and the X-ray detector are arranged to reserve a space therebetween for accommodating tissue to be monitored.
- the tissue to be monitored is a portion of a patient's body which is being monitored during the surgical procedure.
- the X-ray detector produces a plurality of X-ray image data signals, each of which corresponds to an X-ray image of the portion of the patient's body being monitored.
- the X-ray detector produces a digital X-ray image data signal.
- the X-ray image data signal corresponds to a two-dimensional image of the portion of the patient's body being monitored in a preferred embodiment, and corresponds to a three- dimensional X-ray image of the portion of the patient's body in another preferred embodiment.
- the image comparison unit compares X-ray image values between corresponding spatial points of first and second X-ray image signals to provide a resultant X-ray image signal based on the comparison.
- the image comparison unit subtracts pixel values between corresponding spatial points of first and second X-ray image signals, providing a measure of the change in intensity of the received X-ray signal at each point within the digital X-ray image signals.
- the resultant image signal is then one particular example of a difference image signal that is generated by the image comparison unit and then displayed on an image display unit to provide real-time information concerning the temperature distribution and changes in temperature throughout the portion of the patient's body being monitored.
- the images also provide information corresponding to the volume of denatured tissue.
- both the data storage unit and image comparison unit are implemented within a personal computer or workstation.
- Another preferred embodiment of the present invention is directed to a device for causing thermally-induced changes to localized regions of tissue.
- the device according to this preferred embodiment has an X-ray illumination source, an X-ray detector, a data storage unit in communication with the X-ray detector, a thermotherapy heating assembly, an image comparison unit in communication with at least the data storage unit and an image display unit in communication with the image comparison unit.
- the combination of X-ray illumination source, X-ray detector, data storage unit, image comparison unit, and image display unit are constructed and arranged in a manner similar to the monitoring device summarized above.
- the thermotherapy heating assembly may be selected from currently known devices and may include a laser irradiation devices, microwave irradiation devices, radio frequency irradiation device, or an ultra-sound energy source.
- the thermotherapy heating assembly is a laser interstitial thermotherapy assembly.
- laser interstitial thermotherapy assemblies known in the art that are suitable for use with the device for causing thermally-induced changes to localized regions of tissue, in accordance with this invention.
- Another preferred embodiment of this invention is directed to a method of thermally inducing and monitoring changes to localized regions of tissue, including illuminating a volume of tissue with a first beam of X-rays, detecting portions of the first beam of X-rays that pass through localized regions of tissue within the volume of tissue, generating a first X-ray image signal from the portions of the first X-ray beam detected, and applying heat to at least a localized region of tissue within the volume of tissue.
- a preferred embodiment of the method is directed to thermally inducing and monitoring changes to tumors in breast cancer patients. After applying the heat, the volume of tissue is illuminated with a second beam of X-rays.
- the first X-ray image signal is stored in a data storage unit and then retrieved for generating a resultant image signal which preferably is a difference image signal based upon a comparison of the first and second X-ray image signals.
- the first and second X-ray image signals and the difference image signal are digital signals and the difference image signal is formed by subtracting each pixel value of the first X-ray image signal from a spatially corresponding pixel of the second X-ray image signal.
- Each X-ray image signal is correlated with the detected X-ray intensity corresponding to the particular spatial point, and the difference image signal corresponds to an intensity change in the detected X-rays for each corresponding difference image point.
- the difference image signal is rendered as a difference image and displayed on an image display device, preferably, to provide real-time feedback to the surgeon applying thermotherapy. The surgeon can then determine whether to alter the thermotherapy parameters, maintain the thermotherapy, or terminate the thermotherapy with the aid of the temperature change information displayed on the image display device.
- the volume of tissue is illuminated with a third beam of X-rays.
- the X-ray beams may be along the same or modified paths relative to the volume of tissue.
- the X-rays from the third beam that pass through the volume of tissue are detected and a third X-ray image signal is generated therefrom.
- the second and third beam of X-rays may be separated in time by a period in which there is no illumination of X-rays, or it may be a continuous illumination classified as contiguous time periods. Continuous illumination is currently less preferable than intermittent illumination due to safety concerns regarding the total X-ray dose applied to the patient.
- the first X-ray image signal is again retrieved from the data storage unit and used as a static reference image signal to produce a second difference image signal by subtracting each corresponding pixel of the first and second image signals.
- the second difference image signal is then rendered and displayed as an updated difference image which provides updated information to the surgeon, preferably in real time. The surgeon can then use the temperature change information displayed to reassess the status of the thermotherapy to determine whether to alter, continue or terminate the thermotherapy.
- the difference image signal is always generated by retrieving the same static reference image signal from the data storage unit and subtracting it from the updated measurement signal.
- all method steps are the same as those noted above, except that a static reference image signal is not used to generate the difference image signal.
- the first X-ray image signal is replaced by the second X-ray image signal after the first difference image signal is generated.
- the second X-ray image signal stored in the data storage unit is replaced with the third X-ray image signal after the second difference image signal is generated. This process is repeated until the surgeon determines that the thermotherapy should be terminated.
- This case provides a dynamic reference image signal for forming the difference image signal in which the dynamic reference image signal is updated after each succeeding illumination.
- one may combine both static and dynamic processes for generating the difference image signals.
- the reference image signal may be maintained in memory without being replaced for one, two or more successive illuminations, followed by being updated either frequently, such as with a pure dynamic reference image signal, or intermittently, again being a mix of dynamic and static processes.
- Another embodiment of the invention is directed to a method of destroying cancerous tissue by forming a first X-ray image of a portion of a patient's body, applying heat to a localized region of the portion of the patient's body, forming a second X-ray image of the portion of the patient's body subsequent to applying heat to the localized region of the portion of the patient's body, and generating a difference image based on a comparison of the first X-ray image data to the second X-ray image data.
- the surgeon modifies the application of heat based on information obtained from the difference image.
- the first and second X-ray images and the difference X-ray image are high resolution, three-dimensional digital X-ray images.
- the comparison is a subtraction of the first X-ray image from the second X-ray image.
- the illumination with successive X-ray beams, detecting, generating X-ray image signals, and generating successive difference image signals is repeated as the surgeon requires until he terminates the thermotherapy.
- FIGURE 1 is a schematic illustration for explaining general concepts of the invention
- FIGURE 2 is a schematic illustration of a device for causing and monitoring thermally induced changes to localized regions of tissue in accordance with a preferred embodiment of the invention
- FIGURE 3 A is a partially cut-away view of a probe within a heating assembly in a preferred embodiment of this invention
- FIGURE 3B is a side view of an end of the probe illustrated in FIGURE 3A;
- FIGURE 4 is a schematic illustration of applying heat to a tumor in accordance with the preferred embodiment of this invention.
- FIGURE 5 is a flowchart illustrating a preferred embodiment of a method according to this invention.
- FIGURE 6 is a flowchart illustrating another preferred embodiment of a method according to the invention.
- FIGURE 7 is a graph showing average X-ray intensity in the region of interest (diffusing fiber experiment).
- FIGURE 8 is a graph showing average X-ray intensity in the region of interest (bare fiber experiment).
- FIGURE 9 is a schematic illustration of the region of interest with respect to a thermotherapy probe for the experiments of FIGURES 7 and 8;
- FIGURE 10 shows graphs of changes of average X-ray intensity as a function of time for experimental regions of interest as illustrated in FIGURE 9;
- FIGURE 11 illustrates desired hypothermic effects in accordance with the invention
- FIGURE 12 is a plot of intensity data as a function of time over entire images taken every thirty seconds during an experiment in accordance with the invention
- FIGURE 13 is a plot of intensity data as a function of time over whole images taken every six seconds in accordance with the invention.
- FIGURE 14 is a plot of maximum pixel intensities in an experiment in accordance with the invention for thirty second firing sequence of the laser;
- FIGURE 15 is a graph of maximum pixel intensities as a function of time in a second experiment for six second firing sequences of the laser;
- FIGURE 16A illustrates transfer function as a function of intensity on a linear scale
- FIGURE 16B illustrates a transfer function vs. intensity change on a logarithmic scale
- FIGURE 16C illustrates a transfer function vs. intensity change for a desired function
- FIGURE 17A is an initial subtracted image on a linear scale for data taking in accordance with a preferred embodiment of this invention.
- FIGURE 17B is an initial subtracted image on a logarithmic scale for data taken in accordance with a preferred embodiment of this invention.
- FIGURE 18 A is a subtracted image after 3 minutes of laser firing on the linear scale for data taken in accordance with a preferred embodiment of this invention (difference image);
- FIGURE 18B is a subtracted image on a logarithmic scale corresponding to the case of FIGURE 18A (difference image);
- FIGURE 19A is a subtracted image after 7 minutes of laser firing on a linear scale for data taken in accordance with a preferred embodiment of this invention (difference image);
- FIGURE 19B is a subtracted image after 7 minutes of laser firing on a logarithmic scale for the case corresponding to FIGURE 19A (difference image);
- FIGURE 20A is a subtracted image after 4 minutes of cooling down on a linear scale for data taken in accordance with a preferred embodiment of this invention (difference image);
- FIGURE 20B is a subtracted image on a logarithmic scale for the case corresponding to FIGURE 20A (difference image);
- FIGURE 21 A is a subtracted image after 7 minutes of cooling down on a linear scale for data taken in accordance with a preferred embodiment of this invention (difference image);
- FIGURE 2 IB is a subtracted image on a logarithmic scale conesponding to the case of FIGURE 21 A (difference image).
- FIGURE 1 is a schematic illustration of a volume of tissue 100 which contains a localized region of tissue 102.
- the localized region of tissue 102 is a tumor formed of cancerous tissue.
- the volume of tissue 100 is illuminated with a collimated beam of X-rays 104 illustrated schematically in FIGURE 1 as a heavy arrow and also labeled lo representing the intensity of the collimated X-ray beam.
- the collimated X-ray beam 104 has a plurality of beam portions, one of which is labeled 106 in FIGURE 1, that pass through a portion of the volume of tissue 100 for a distance 108 before reaching the depth of the tumor 102.
- the tumor 102 is represented as having a simple structure in FIGURE 1 for the purpose of illustrating the general concept of the invention.
- the tumor 102 has a uniform thickness 110 along the direction of the path of the X-ray beam 104.
- the X-ray beam is illustrated as a collimated beam to facilitate the discussion.
- the X-ray beams emitted by sources currently used are diverging beams. Portions of the X-ray beam such as 106 pass through the volume of tissue 100 without passing through the tumor 102 and emerge from the volume of tissue 100 at an opposing side 112 of the volume of tissue 100.
- the volume of tissue 100 is also assumed to have a simple structure in which it has a uniform width which is the sum of the distances 108 to reach the tumor 102, plus the distance 110 in order to pass by or through the tumor 102, plus the distance 114 to pass from an opposing end 116 of the tumor 102 to exit the volume of tissue 100 at the opposing end 112 of the volume of tissue 100.
- electromagnetic radiation has a dual nature in which it can be thought of as a collection of a plurality of photons, or may be thought of as an electromagnetic wave or waves.
- the particle view is convenient to imagine that the X-ray beam is a collection of a large number of particles, i.e., photons, in which some of the plurality of photons traverse a path which misses the tumor 102, while another plurality of photons traverse a path through the volume of tissue 100 and then pass through the tumor 102.
- Photons traveling along a path 106 miss the tumor 102 and exit the volume of tissue 100 at the opposing end 112 after traveling through a distance of tissue which is the sum of the distances 108, plus 110, plus 114.
- the collection of all photons which pass above the tumor 102 in FIGURE 1 and exit the opposing end 112 of the volume of tissue 100 together form an intensity sub-beam 118, as illustrated in FIGURE 1, without passing through a tumor 102.
- a portion of the X-ray beam 104 that passes through the volume of tissue 100 to emerge at the opposing end 112 below the tumor 102, as illustrated in FIGURE 1, without passing through the tumor 102 forms a sub-beam intensity 120.
- the above-described schematic illustration can also be modeled mathematically.
- the incident intensity is represented as lo and the detected intensity at a position x, y, in the plane perpendicular to the figure at opposing end 112 of the volume of tissue 100, is represented as
- ⁇ (x,y,z) is the attenuation coefficient at each three-dimensional point within the volume of tissue.
- the lengths 108, 110 and 114 are represented as ⁇ ⁇ , z 2 and z 3 , respectively.
- a photon passing along the line 106 and exiting the volume of tissue 100 at the opposing end 112 is assumed to traverse a substantially homogeneous region of tissue in which the attenuation coefficient is constant in the Z-direction, and represented by ⁇ j.
- the intensity of X-rays passing through a portion of the volume of tissue 100 within the region 118 is then represented as
- ⁇ 2 is the attenuation coefficient within the tumor which is substantially constant along the Z-direction
- the attenuation coefficient ⁇ 2 is generally different from the attenuation coefficient ⁇ i.
- the intensity 1 ⁇ varies with temperature. If there was no variation in X-ray attenuation properties of the tumor with respect to changes in temperature, then b would be equal to zero, and the second factor in equation 6 would be equal to unity. In that case, comparing the intensity of X-rays sent through the tumor at different temperatures would lead to substantially the same intensity. However, since there is a temperature variation in the attenuation properties of X-rays by the tumor, the intensity according to equation 6 at a temperature Ti is different from that of another temperature T 2 . This temperature-dependent variation in X-ray attenuation by the tumor can be exploited by observing the change in intensity Ii as the temperature changes. For example, the ratio of the intensity at temperature T 2 to the intensity at temperature T ⁇ , according to equation 6 can be represented as
- equation 7 If there were no temperature variation in the X-ray attenuation coefficient of the tumor 102, equation 7 would be equal to unity. The deviations from unity signify the temperature variations in the intensity of X- rays passing through the tumor 102. The ratio of intensities in this case is taken as a measure to recognize the change in intensity of X-rays passing through the tumor 102 with changes in temperature. However, the invention includes generally comparing the changes in intensity of X-rays passing through tumors that are correlated with changes in temperature and changes induced by temperature.
- Another useful method of comparing the changes of intensity of X-rays passing through the tumor with changes in temperature is to subtract the intensity values.
- This invention is directed generally to the concept of utilizing such a change in X- ray intensity with a change in temperature in methods and devices.
- LITT laser interstitial thermotherapy
- the inventors have found that the temperature increase generated during LITT will cause a change in the X-ray density of the heated tissue which is detectable in accordance with this invention.
- thermal denaturation causes a variation in tissue X-ray density which is detectable according to this invention.
- the LITT procedure will be described in detail in the preferred embodiment; however, the general concepts of the invention include other mechanisms now known, and later developed which lead to heating tumor tissue.
- lasers which irradiate tissue with electromagnetic radiation in regions other than the near infra-red region are all mechanisms that can be used to heat tumor tissue.
- the heat sources may be internally applied heat sources such as the LITT method, or they may be external sources.
- the preferred embodiments describe applications to breast cancer in particular detail.
- tissue monitoring and treatment is included within the general concept of the invention.
- the inventors anticipate that choroidal tumors of the eye, prostate cancer, and liver cancer are also particularly suitable for tumor monitoring and treatment according to this invention.
- this invention is generally applicable to monitoring temperature changes in localized regions of tissue whenever the localized regions of tissue have a temperature variation in X-ray attenuation compared to a surrounding volume of tissue.
- FIGURE 2 An example of a thermal therapy device in accordance with a preferred embodiment of this invention is illustrated in FIGURE 2, and labeled generally by reference numeral 124.
- the thermal therapy device 124 has a monitoring unit 126 and a heating assembly 128.
- the monitoring unit 126 has an X-ray illumination source 130 and an X-ray detector 132 disposed proximate to the X-ray illumination source 130.
- a space is reserved between an X-ray illumination source 130 and X-ray detector 132 for accommodating tissue to be monitored, and/or treated, such as a portion of a person's body.
- a woman's breast 134 is arranged between the X-ray illumination source 130 and the X-ray detector 132 for the treatment and treatment monitoring of breast cancer.
- a compression plate 136 compresses the patient's breast 134 in contact with the X-ray detector 132.
- the monitoring unit 126 has a data storage unit 138 that is in communication with the X-ray detector 132.
- the monitoring unit 126 also has an image comparison unit 140 that is in communication with at least the data storage unit 138 (see, the dashed line in FIGURE 2).
- the image comparison unit 140 is in communication with both the X-ray detector 132 and the data storage unit 138.
- the image comparison unit 140 is in communication with an image display unit 142.
- the image display unit 142 may be a separate specially designed display unit, or may be the monitor of a personal computer or workstation 144.
- Each of the image comparison unit 140 and data storage unit 138 may be separate dedicated components, or may be implemented on the personal computer or workstation 144. Furthermore, the image comparison unit 140 may be a stand-alone special function component, or may be implemented by programming the personal computer 144. Special function stand-alone units typically allow one to optimize performance, but at a higher cost.
- the X-ray detector 132 is a digital detector that produces a digital X-ray image signal.
- the invention is not limited to digital X-ray detectors, and includes analog detectors producing analog X-ray image signals.
- the X-ray detector 132 has a fluorescent screen 146 which fluoresces in the visible region of the electromagnetic spectrum upon being struck by X-rays from X-ray illumination source 130.
- the light emitted by the fluorescent screen is detected by an array of
- the monitoring unit 126 employs a three- dimensional X-ray imaging system, such as stereotactic X-ray imaging.
- the MAMMOVISION ® system 85200G-2 produced by Fischer Imaging Company was found to be suitable for use in the monitoring unit 126.
- the heating assembly 128 is a laser interstitial thermal therapy assembly.
- the LITT assembly 128 has a MAMMOGRAPHIC thermal ablative therapy probe 148 attached to sled 150 which is controlled by a data acquisition system and control unit 152.
- An optical fiber 154 is attached to the probe 148 to transport the laser energy from the laser 156.
- the laser is a continuous wave Nd:YAG laser.
- the invention anticipates that other lasers such as semiconductor lasers and gas lasers will be used in particular applications. Furthermore, it is anticipated that pulsed lasers may be suitable in some applications.
- the LITT assembly 128 also has a plurality of thermocouples 158. The insertion portion of the probe 148 is shown in more detail in FIGURES 3 A and 3B.
- the outer layers of the probe 148 are cut-away in cross-section in FIGURE 3 A to show a cross-sectional view of the quartz diffusing cap 160 and a cross-sectional view of the stainless steel tube 162.
- the probe 148 has two thermocouples 164 and 166, respectively.
- the optical fibre 168 is exposed in the cut-away view of the quartz diffusing cap 160 and stainless steel tube 162.
- FIGURE 3B shows a side view corresponding to FIGURE 3 A.
- FIGURE 4 is a schematic illustration of the probe 148 inserted into a tumor 170 within a surrounding volume of tissue 172.
- FIGURE 5 illustrates a preferred embodiment of a method of thermally inducing and monitoring changes to localized regions of tissue, in accordance with the invention.
- a region of tissue 134 arranged between the X-ray illumination source 130 and the X-ray detector 142 is illuminated with a first beam of X-rays (see, FIGURE 2 in conjunction with FIGURE 5).
- the X-ray detector 132 detects a plurality of portions of the first beam of X-rays after they have passed through the volume of tissue 134.
- the X-ray detector 132 generates a first X-ray image signal from a plurality of portions of X-rays detected from the first beam of X-rays.
- the first X- ray image signal is a digital signal.
- the general concept of the invention includes generating an analog X-ray image signal, rather than a digital X-ray image signal.
- the first X-ray image signal generated is a static reference X-ray image signal which is stored in a data storage unit 138 for later retrieval.
- Heat is then applied to the tissue using an appropriate heating assembly for thermal therapy.
- heat may be applied with the LITT assembly 128 illustrated in FIGURE 2.
- the heat application assembly may be selected according to the particular use from known heating assemblies such as various laser assemblies, microwave heating, radio frequency heating or ultrasound heating assemblies.
- the tissue 134 is then illuminated with a second beam of X-rays at a second time.
- the X-ray detector 132 detects a plurality of portions of the second beam of X-rays that pass through the volume of tissue from the second beam of X-rays.
- the X-ray detector generates a second X-ray image signal from the plurality of portions of the second X-ray beam detected, which is preferably a digital X-ray image signal.
- a resultant image signal is generated based upon a comparison between the first and second X-ray image signals generated.
- the resultant image signal is a difference image signal generated by subtracting each pixel of image data of the first digital X-ray image signal from each corresponding pixel of the second digital X-ray image signal.
- the digital X-ray image signals are rendered as two-dimensional, and/or three- dimensional images, the pixel-by-pixel subtraction will correspond to subtractions at the same spatial location within the corresponding two- dimensional and/or three-dimensional image.
- the difference image signal generated is based upon a subtraction of image values in the prefened embodiment, the general concept of the invention is not limited to only subtracting image values.
- a ratio between conesponding values could be taken, or innumerable other mathematical operations could be performed, as suitable, such as dividing all values by a normalization factor, etc.
- groups of pixels may first be combined in various ways, such as pixel averaging prior to the generating a difference image signal.
- the image may be preprocessed by two-dimensional and/or three-dimensional Fourier transformation and comparing the images in the spatial-frequency domain either with or without prior spatial filtering.
- the difference image signal is rendered as an image, preferably rendered as a real-time image on a display screen to provide information during thermal therapy.
- the displayed image of the difference signal provides information on the size and/or volume of localized regions of tissue, such as denatured tissue, as well as the rate of temperature changes or temperature- induced changes and the corresponding relative temperatures.
- the user may employ the displayed information to determine whether desired regions of tissue are receiving enough, or too much, heat, as well as determining the extent of tissue necrosis due to the thermal therapy.
- the displayed image may be utilized by the user to determine whether to continue the thermal therapy and to determine whether the heat application parameters need to be altered. For example, the amount of heat applied may be increased, or decreased, or the location where the heat is being applied may be altered.
- the heat application may be a continuous process in which the successive applications of heat may be considered to be contiguous time intervals. Alternatively, the heat may be applied in separate intervals, separated by periods in which no heat is applied to the tissue by the heat application assembly.
- the region of tissue is then illuminated with another beam of X-rays in which portions are detected by the X-ray detector after they pass through the tissue.
- the beams of X-rays illuminating the tissue may be discrete illumination periods separated by non-illumination periods, or may be contiguous time periods forming a continuous illumination by X-rays classified in time intervals.
- the X-rays detected after the third illumination beam of X-rays lead to a third digital X-ray image signal generated according to the prefened embodiment of the invention.
- the same reference X-ray signal is retrieved from the data storage unit as was previously retrieved from the data storage unit. In this embodiment of the invention, the same reference X-ray image signal is used to generate difference image signals a plurality of times. This reference X-ray signal is thus called a static reference X-ray signal to indicate that it will remain unchanged for at least a plurality of difference image signals generated.
- the user After retrieving the static reference X-ray image signal from the data storage unit and generating a second resultant image signal, preferably a difference image signal, it is then rendered on a display screen.
- a second resultant image signal preferably a difference image signal
- the user has the displayed image available to update determinations on size and/or volume of the cancerous and/or necrotic tissue as well as a temperature map, or map of temperature-induced changes, and temperature change map within the tissue area of observation. This process may then be repeated numerous times until the surgeon determines that the thermal therapy should be terminated.
- the general concepts of the invention include generating both two- dimensional, and three-dimensional X-ray image signals (e.g., stereotactic X- ray imaging), and generating the conesponding resultant X-ray image signals.
- three-dimensional X-ray image signals are produced.
- at least two X-ray beams through a given point within the illumination tissue must be detected.
- the X-ray illumination source and or detector may be moved relative to a tissue being illuminated, or there may be a plurality of illumination sources and/or X-ray detection elements.
- FIGURE 6 illustrates another prefened embodiment of a method of thermally inducing and monitoring changes to localized regions of tissue in accordance with the invention.
- the description of the method of the prefened embodiment in FIGURE 5 carries over to many of the steps illustrated in FIGURE 6.
- the reference signal generated and stored in the data storage unit is a dynamic reference signal which is updated subsequent to each resultant image signal that is generated.
- the second X-ray image signal replaces the first X-ray image signal in the data storage unit to become the up- dated dynamic reference signal.
- Heat is then applied to the tissue, followed by illumination of the tissue with a third beam of X-rays.
- the third beam of X- rays is detected after passing through the tissue illuminated with the X-rays, and a third X-ray signal is generated.
- the dynamic reference X-ray image signal is retrieved from the data storage unit and subtracted, pixel by pixel, from the third X-ray image signal to generate a second difference image signal.
- the second difference image signal is rendered and displayed on a display unit for a user to determine the various physical properties of the localized regions of tissue. If the surgeon determines that thermal therapy should continue, the third X-ray image signal replaces the previously X-ray signal in the data storage unit to become the up-dated dynamic reference image signal. This process is continued repeatedly until the surgeon determines that thermal therapy should be terminated.
- FIGURES 5 and 6 describe using either a static reference X-ray image signal, or a dynamic reference X- ray image signal.
- the general concept of the invention includes a combination of both static and reference image signals in which the reference signal may be static for a period of time, dynamically updated and then could become static again to provide an unlimited range of possible combinations between the two limits.
- MAMMOVISION System (85200G-2, Fischer Imaging Co, Denver, CO) during laser-inadiation of porcine fatty tissue with a 980 nm diode laser (AOC 25, AOC Medical Systems, South Plainfield, NJ).
- the Experimental Method A 20 x 8 x 3 cm piece of fatty porcine tissue with the skin was compressed at room temperature of 25 °C with the MAMMOVISION compression paddle.
- an optical fiber with a diffusing tip with a diameter of 1.7 mm (REM series B) was inserted in the tissue after making a path with a stainless steel trocar.
- the sequence was set to take exposures every 30 seconds, although the system actually took exposures every 32 seconds.
- the generator settings were 25 kV, 100 mA, and 90 mAs.
- the laser was fired continuously at 10 W starting after the first auto-firing exposure for approximately 9 minutes. After approximately 2 minutes, we moved the fiber back so that the tip would appear in the images. After the 18th exposure we turned off the laser and continued to take exposures for 2 minutes.
- a bare fiber with a 0.6 mm diameter was used (3M series B).
- the experimental procedure was the same as with the diffusing fiber.
- the generator settings were 25 kV, 100 mA, and 50 mAs.
- the laser was fired from between the third and 15th exposures and again took images for two minutes of the cooling down period. It should also be noted that we varied the laser power from 5 to 10 W after one minute and from 10 to 15 W after another two minutes.
- the average intensity (in arbitrary units conesponding to X-ray density) in a region of interest sunounding the optical fibers was recorded for each image.
- the average intensity of the region of interest increases approximately linearly during laser treatment of the tissue (FIGURES 7 and 8).
- the rates at which the average intensity increases are 34 units/min for the diffusing tip experiment and 54 units/min for the bare fiber experiment.
- the average intensities of the regions of interest decrease, although not to their initial levels. Both the average intensity increase during laser treatment and the decrease after laser treatment are higher in the bare fiber experiment. Note:
- the increases in the average intensity may either be a result of changes in the tissue density or to the camera's sensitivity to heat.
- a 20 x 8 x 3 cm piece of fatty porcine tissue with the skin was compressed at room temperature of 25 °C with the MAMMOVISION compression paddle.
- An optical fiber (REM Series B) with a diffusing tip of diameter 1.7 mm was inserted in the tissue after making a path with a stainless steel trocar (2.1 mm diameter). The laser was fired for 6 minutes at 10 W after the first image was taken and turned off for the remainder of the experiment.
- the auto-firing sequence was set to take images ever 30 seconds for the first 30 exposures, although the system actually took exposures every 32 seconds. At this point (approximately 15 minutes into the experiment), the auto-firing sequence was set to take exposures every 6 seconds.
- the difference between the exposures was measured quantitatively by obtaining the average intensity (in arbitrary units conesponding to the optical density) in different regions of interests above and below the optical fiber 148 (see, FIGURE 9). Regions directly sunounding the fiber were not studied because the fiber appears to shift through the images and its appearance in a region where it was not initially placed would skew the average intensity.
- the following graphs in FIGURE 10 illustrate the average intensity increases during the firing of the laser (the first six minutes) and decrease and level off during the remainder of the experiment.
- the regions closer to the optical fiber show a more significant increase in average intensity during the laser inadiation than the regions further away.
- the lO x 10 x 4 cm PMMA calibration block at room temperature (25°C) was held in place before the MAMMOTEST camera with the compression paddle.
- the auto-firing sequence was set to take exposures every 30 seconds for approximately 15 minutes (after the initial scout and stereo images were taken). The initial scout was taken in the Autoexposure mode and its parameters were used in the sequential firing.
- the generator was set manually at 25 kV, 280 mAs, and 100 mA for the sequential firing. The first image was accidentally taken at automatic generator settings and was not included in the data discussed below.
- the auto-firing sequence was set to take exposures every 6 seconds for 3 minutes. The generator settings were set manually at 26 kV, 280 mAs, 100 mA.
- the final experiment compared the effect of placing an additional 0.5 cm PMMA plate, which will be used in the tissue phantom holder, between the camera and the phantom on the average pixel intensity.
- Three images (an initial scout and two stereo images) were taken at generator settings of 26 kV, 380 mAs, 100 mA.
- the average intensity of the images in the first and second experiments are within 0.5% and 0.2%, respectively (FIGURES 12 and 13).
- the standard deviations of the average intensities are too small to be visible in FIGURES 12 AND 13.
- the maximum pixel intensities in both experiments show large variations. Much of these variations disappear when analyzing the center 40 x 40 mm region, suggesting that the artifact causing these variations occurs more frequently in the edges of the images (see, FIGURES 14 and 15).
- the variations do not appear in a 30 x 30 mm center region.
- the minimum intensity values remained virtually unchanged in the center region (Tables 1- 2). According to Tables 3-4, the maximum intensity occurs on the same few pixels throughout the experiment. In both experiments, the maximum intensity value occurs mostly on pixel coordinates (628, 1020, maximum intensity ⁇ 3170) and (1018, 179, maximum intensity ⁇ 2400).
- the average of the average intensities of the images taken in the last experiment with the additional PMMA plate is 1393, or 66% of the value without the plate, which indicates that the plate introduces a significant attenuation.
- this effect may be compensated for by using other X- ray generator parameters.
- the minumum pixel intensity is zero and conesponds to total attenuation (i.e., no X-ray photons reaching the camera) and a white image.
- the maximum pixel intensity is 4095 and conesponds to no attenuation (i.e., all X-ray photons reaching the camera) and a black image.
- Each pixel conesponds to an area of approximately 50 x 50 ⁇ m.
- Table 1 Pixel intensity data of Experiment 1 (30 s firing rate, 25 kV, 280 mAs, 100 mA)
- Table 3 Values and pixel coordinates of maximum intensities
- the images taken with the MAMMOVISION system are 50 x 50 mm images containing 1024 x 1024 pixels with each pixel conesponding to a 50 x 50 ⁇ m area. Since the desired target volume is 30 mm in diameter, the main region of interest (ROT) during treatment is a 30 x 30 mm area in the image.
- ROT main region of interest
- the resolution of the images is much greater for each image than is necessary for thermal imaging; where a resolution on the order of 1 x 1 mm is sufficient. It is therefore beneficial to convert the images from 1024 x 1024 pixels to a smaller resolution by averaging blocks of the 1024 x 1024 into one pixel (see, Table 4). Another benefit of reducing the resolution is removing the noise effects generated by a few unstable pixels.
- the PMMA calibration block (lO x 10 x 4 cm) was held in place before the MAMMOVISION (85200G-2, Fischer Imaging Co., Denver, CO) camera with the compression paddle at room temperature (25 °C).
- the initial scout was taken at 0° in the Autoexposure mode and its parameters were used in the subsequent firing.
- the generator was set manually at 25 kV, 280 mAs, and 100 mA for the sequential firing.
- the auto-firing sequence was set to take exposures every 30 seconds for approximately 14 minutes for a total of 27 images.
- a Turbo C program was written to find pixels that changed in intensity by more than 20% between two successive images.
- This subsection describes results of quantifying the stability of the pixel intensities of 128 x 128 averaged images.
- the images used in the previous analysis were converted from 1024 x 1024 pixel images into 128 x 128 pixel images by averaging 8 x 8 pixel blocks into one pixel, by using a Turbo C program. These images were then analyzed by another Turbo C program to find pixels that changed in intensity by more than 2%.
- This subsection describes displaying the changes in X-ray intensity of laser-inadiated tissue in color according to this invention.
- the images of the laser-inadiated fatty porcine tissue were obtained from a previous experiment.
- a 20 x 8 x 3 cm piece of fatty porcine tissue with the skin was compressed at room temperature of 25 °C with the MAMMOVISION compression paddle.
- An optical fiber (REM Series B) with a diffusing tip of diameter 1.7 mm was inserted in the tissue after making a path with a stainless steel trocar (2.1 mm diameter). The laser was fired for 6 minutes at 10 W after the first image was taken and turned off for the remainder of the experiment.
- FIGURES 17A-21B the changes in the tissue sunounding the fiber are evident. The changes are more apparent in the logarithmic scale than in the linear scale. Movement of the fiber during the experiment cause the red and white regions at the original location of the fiber and the dark blue region at the actual location of the fiber.
- the scale will not amplify the temperature range of most interest to hyperthermia when the intensity changes are conelated with temperature (see, FIGURES 16 A, 16B and 16C).
- the temperature range that needs to be monitored most closely in this embodiment of the invention is between 55 and 65 °C, which is expected to be in the middle or higher (red) end of the range of intensity changes. Temperatures above 65 °C do not need to be monitored by temperature.
- a more suitable transfer function may be developed to be converted to a color scale (see, FIGURES 16A-21B).
- the minimum pixel intensity is zero and conesponds to total attenuation (i.e., no X-ray photons reaching the camera) and a white image.
- the maximum pixel intensity is 4095 and conesponds to no attenuation (i.e., all X-ray photons reaching the camera) and a black image. After the images are subtracted, the maximum possible intensity range is from -4095 to 4095.
- This subsection presents an analysis of a stability test of the MAMMOVISION System (85200G-2, Fischer Imaging Co., Denver, CO) exposures on fatty porcine tissue during the auto-firing sequence in accordance with this invention.
- An approximately 20 x 8 x 3 cm piece of fatty porcine tissue with the skin was compressed at room temperature 20°C with the MAMMOVISION compression paddle.
- the initial scout was taken in the Autoexposure mode and its parameters were used in the sequential firing.
- the generator was set manually at 25 kV, 50 mAs, and 100 mA for the following images in the sequential firing.
- the auto-firing sequence was set to take exposures every 30 seconds for approximately 15 minutes (after the initial scout and stereo images were taken).
- the images obtained from this sequence were converted from 1024 x 1024 pixel images into 128 x 128 pixel images by averaging 8 x 8 pixel blocks into one pixel, by using a Turbo C program. These images were then analyzed by another Turbo C program to find pixels that changed in intensity by more than 2%.
- Table 7 Coordinates and image number of pixels with over 2% intensity change in the 128 x
- the minimum pixel intensity is zero and conesponds to total attenuation (i.e., no X-ray photons reaching the camera) and a white image.
- the maximum pixel intensity is 4095 and conesponds to no attenuation (i.e., all X-ray photons reaching the camera) and a black image.
- Each pixel conesponds to an area of approximately 50 x 50 ⁇ m in the 1024 x 1024 pixel images and to approximately 0.4 x 0.4 mm in the 128 x 128 pixel images.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
La présente invention concerne un procédé permettant d'induire par la chaleur et de surveiller des modifications de régions de tissus localisées Le procédé de l'invention consiste à : illuminer un volume de tissu à l'aide d'un premier faisceau de rayons X, détecter les parties du premier faisceau de rayons X qui ont traversé le volume de tissu, produire un premier signal-image radiologique à partir des parties des rayons X du premier faisceau détectées, appliquer de la chaleur sur au moins une région localisée de tissu comprise dans le volume de tissu après l'illumination et après la détection, illuminer le volume de tissu à l'aide d'un deuxième faisceau de rayons X, détecter les parties du deuxième faisceau de rayons X qui ont traversé le volume de tissu au cours de l'illumination par le deuxième faisceau de rayons X, produire un deuxième signal-image radiologique à partir des parties des rayons X du deuxième faisceau détectées, et produire un signal-image de différence basé sur la comparaison entre le premier et le deuxième signal-image radiologique. Le signal-image de différence fournit des informations sur les modifications qu'entraîne l'application de la chaleur dans l'atténuation des rayons X par les régions de tissu localisées à l'intérieur du volume de tissu.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06013771A EP1719542A1 (fr) | 1999-04-22 | 2000-04-21 | Surveillance préopératoire des modifications tissulaires induites par la température a l'aide d'un appareil de radiographie numérique a haute résolution au cours d'une thermothérapie |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13049799P | 1999-04-22 | 1999-04-22 | |
| US130497P | 1999-04-22 | ||
| PCT/US2000/010814 WO2000064536A1 (fr) | 1999-04-22 | 2000-04-21 | Surveillance peroperatoire des modifications tissulaires induites par la temperature a l'aide d'un appareil de radiographie numerique a haute resolution au cours d'une thermotherapie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06013771A Division EP1719542A1 (fr) | 1999-04-22 | 2000-04-21 | Surveillance préopératoire des modifications tissulaires induites par la température a l'aide d'un appareil de radiographie numérique a haute résolution au cours d'une thermothérapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1171202A1 true EP1171202A1 (fr) | 2002-01-16 |
Family
ID=22444973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00926246A Withdrawn EP1171202A1 (fr) | 1999-04-22 | 2000-04-21 | Surveillance peroperatoire des modifications tissulaires induites par la temperature a l'aide d'un appareil de radiographie numerique a haute resolution au cours d'une thermotherapie |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1171202A1 (fr) |
| AU (1) | AU4480700A (fr) |
| WO (1) | WO2000064536A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8556888B2 (en) | 2006-08-04 | 2013-10-15 | INTIO, Inc. | Methods and apparatuses for performing and monitoring thermal ablation |
| US8155416B2 (en) | 2008-02-04 | 2012-04-10 | INTIO, Inc. | Methods and apparatuses for planning, performing, monitoring and assessing thermal ablation |
| US7871406B2 (en) | 2006-08-04 | 2011-01-18 | INTIO, Inc. | Methods for planning and performing thermal ablation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01218466A (ja) * | 1988-02-26 | 1989-08-31 | Shimadzu Corp | 温熱治療装置 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078142A (en) | 1989-11-21 | 1992-01-07 | Fischer Imaging Corporation | Precision mammographic needle biopsy system |
| DE4229817C2 (de) * | 1992-09-07 | 1996-09-12 | Siemens Ag | Verfahren zur zerstörungsfreien und/oder nichtinvasiven Messung einer Temperaturänderung im Inneren eines insbesondere lebenden Objektes |
| US5365562A (en) | 1993-09-20 | 1994-11-15 | Fischer Imaging Corporation | Digital imaging apparatus |
| US5526394A (en) | 1993-11-26 | 1996-06-11 | Fischer Imaging Corporation | Digital scan mammography apparatus |
| EP0864075A1 (fr) * | 1995-11-28 | 1998-09-16 | DORNIER MEDICAL SYSTEMS, Inc. | Procede et systeme de thermographie tissulaire non invasive |
| US5917881A (en) | 1997-05-20 | 1999-06-29 | Fischer Imaging Corporation | Digital scan mammography apparatus utilizing velocity adaptive feedback and method |
-
2000
- 2000-04-21 EP EP00926246A patent/EP1171202A1/fr not_active Withdrawn
- 2000-04-21 AU AU44807/00A patent/AU4480700A/en not_active Abandoned
- 2000-04-21 WO PCT/US2000/010814 patent/WO2000064536A1/fr not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01218466A (ja) * | 1988-02-26 | 1989-08-31 | Shimadzu Corp | 温熱治療装置 |
Non-Patent Citations (2)
| Title |
|---|
| Bentzen S.M. et al: Isotherm mapping in hyperthermia using subtraction X-ray computed tomography; Radiotherapy and Oncology, 1984, pages 255-260 * |
| See also references of WO0064536A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4480700A (en) | 2000-11-10 |
| WO2000064536A1 (fr) | 2000-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6684097B1 (en) | Intraoperative monitoring of temperature-induced tissue changes with a high-resolution digital x-ray system during thermotherapy | |
| US8948851B2 (en) | Method and apparatus for depth-resolved fluorescence, chromophore, and oximetry imaging for lesion identification during surgery | |
| US6839586B2 (en) | Use of multiphoton excitation through optical fibers for fluorescence spectroscopy in conjunction with optical biopsy needles and endoscopes | |
| WO2013177061A1 (fr) | Cartographie tridimensionnelle et thérapie contre le cancer de la prostate | |
| JP2011115658A (ja) | 周辺光条件下のインビボ誘導信号の光学画像化 | |
| WO2001078830A2 (fr) | Appareil de traitement par photostimulation et procedes d'utilisation associes | |
| US20230389800A1 (en) | Contactless System and Method for Assessing Tissue Viability and Other Hemodynamic Parameters | |
| De Landro et al. | Hyperspectral imaging for thermal effect monitoring in in vivo liver during laser ablation | |
| WO2023028482A1 (fr) | Capteur optique pour surveiller des changements induits par la température dans des tissus biologiques | |
| Milne et al. | Development of stereotactically guided laser interstitial thermotherapy of breast cancer: In situ measurement and analysis of the temperature field in ex vivo and in vivo adipose tissue | |
| Case et al. | Noninvasive enhanced mid-IR imaging of breast cancer development in vivo | |
| US6847700B1 (en) | Method and apparatus for delivery of x-ray irradiation | |
| WO2000064536A1 (fr) | Surveillance peroperatoire des modifications tissulaires induites par la temperature a l'aide d'un appareil de radiographie numerique a haute resolution au cours d'une thermotherapie | |
| EP1719542A1 (fr) | Surveillance préopératoire des modifications tissulaires induites par la température a l'aide d'un appareil de radiographie numérique a haute résolution au cours d'une thermothérapie | |
| CN103648424B (zh) | 能量施加规划设备 | |
| Straight et al. | Application of charge‐coupled device technology for measurement of laser light and fluorescence distribution in tumors for photodynamic therapy | |
| Clancy et al. | Spectral imaging of thermal damage induced during microwave ablation in the liver | |
| Palombi et al. | Endovascular laser treatment. Comparison of lasers and fibers of different generations: study of temperatures and tissue damage produced on a porcine liver model | |
| Shiryaev et al. | Investigated spectral-fluorescent properties of endogenous porphyrins of the wild boar hepatobiliary system optimize the diagnostics and treatment of cholangiocarcinoma with FD and PDT | |
| De Landro et al. | Hyperspectral imaging system for monitoring laser-induced thermal damage in gastric mucosa | |
| Thomas et al. | Optimized laser application in dermatology using infrared thermography | |
| US20250169708A1 (en) | Enhanced thermal imaging for the intraoperative detection of microvasculature and the intraoperative and postoperative monitoring of blood perfusion | |
| Saccomandi et al. | Real-time temperature monitoring and estimation of thermal damage in pancreas undergoing magnetic resonance-guided laser ablation: First in vivo study | |
| Zharov et al. | Photothermal/microwave radiometry for imaging and temperature feedback | |
| Saccomandi et al. | Laser ablation in biliary tree: analysis of the intraductal and superficial thermal effects during the treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20011031 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RBV | Designated contracting states (corrected) |
Designated state(s): DE FR GB IT |
|
| 17Q | First examination report despatched |
Effective date: 20040830 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20061207 |